revatio

Showing 2 posts of 2 posts found.

Pfizer

Pfizer’s Revatio extends Europe PAH licence

May 9, 2011
Sales and Marketing PAH, Pfizer, pulmonary arterial hypertension, revatio

Pfizer’s Revatio has been approved by European regulators for the treatment of pulmonary arterial hypertension (PAH) in children.The European Commission has …

Pfizer adds another product to its PAH franchise

May 14, 2010
Research and Development Ergonex, PAH, Pfizer, Thelin, revatio, terguride, viagra

Pfizer has signed an agreement to acquire terguride, a drug for pulmonary arterial hypertension (PAH) currently in phase II testing, …

The Gateway to Local Adoption Series

Latest content